Literature DB >> 27538776

Single dose IOERT versus whole breast irradiation : Cosmetic results in breast-conserving therapy.

Henk Struikmans1,2, Malou Snijders3, Mirjam E Mast3, Ursula Fisscher3, Jan-Huib Franssen4, Marcelle J Immink5,6, Andreas Marinelli7, Jos Merkus8, Anna Petoukhova3, Gabrielle Speijer4, Peter Koper3.   

Abstract

BACKGROUND: Scarce data are available about the cosmetic result of single dose intraoperative electron radiotherapy (IOERT) in breast-conserving radiotherapy. METHODS AND MATERIALS: We included 71 breast cancer patients. Breast-conserving surgery and sentinel node procedure had started almost 3 years earlier. Subsequently, 26 patients were treated with IOERT and 45 patients received postoperative whole breast irradiation (WBI). For both groups we determined seven dimensionless asymmetry features. We compared the subjectively and the objectively derived cosmetic scores with each other.
RESULTS: For four asymmetry features we noted significantly smaller differences for patients treated with IOERT when compared to those treated with WBI: relative breast contour difference, relative breast area difference and relative breast overlap difference. After correcting for excision volume a significant difference was noticed also for relative lower breast contour. For the IOERT group the cosmetic scores "excellent or good" as determined by each patient and one physician were 88 and 96 %, respectively. When the overall cosmetic scores for patients treated with IOERT and WBI were compared to those of the objectively derived scores, there was a fair level of agreement.
CONCLUSION: For patients treated with IOERT we noted less asymmetry and high rates of "good or excellent" subjectively derived cosmetic scores. The level of agreement between the subjectively and the objectively derived cosmetic scores was limited. Due to the small sample size and the design of the study no definitive conclusions can be drawn.

Entities:  

Keywords:  Accelerated partial breast irradiation; Asymmetry; Intraoperative electron radiotherapy; Lumpectomy; Radiotherapy

Mesh:

Year:  2016        PMID: 27538776     DOI: 10.1007/s00066-016-1029-1

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  30 in total

1.  Altered fractionation: rationale and justification for whole and partial breast hypofractionated radiotherapy.

Authors:  Valérie Théberge; Tim Whelan; Simona F Shaitelman; Frank A Vicini
Journal:  Semin Radiat Oncol       Date:  2011-01       Impact factor: 5.934

2.  Understanding interobserver agreement: the kappa statistic.

Authors:  Anthony J Viera; Joanne M Garrett
Journal:  Fam Med       Date:  2005-05       Impact factor: 1.756

3.  Influence of concurrent anastrozole on acute and late side effects of whole breast radiotherapy.

Authors:  Vladimir Valakh; Mark G Trombetta; E D Werts; George Labban; Mian K Khalid; Anna Kaminsky; David Parda
Journal:  Am J Clin Oncol       Date:  2011-06       Impact factor: 2.339

4.  Role of breast reconstructive surgery in physical and emotional outcomes among breast cancer survivors.

Authors:  J H Rowland; K A Desmond; B E Meyerowitz; T R Belin; G E Wyatt; P A Ganz
Journal:  J Natl Cancer Inst       Date:  2000-09-06       Impact factor: 13.506

5.  Aesthetics in breast conserving therapy: do objectively measured results match patients' evaluations?

Authors:  Joerg Heil; Julia Dahlkamp; Michael Golatta; Joachim Rom; Christoph Domschke; Geraldine Rauch; Maria Joao Cardoso; Christof Sohn
Journal:  Ann Surg Oncol       Date:  2010-08-10       Impact factor: 5.344

6.  The influence of patient, tumor and treatment factors on the cosmetic results after breast-conserving therapy in the EORTC 'boost vs. no boost' trial. EORTC Radiotherapy and Breast Cancer Cooperative Groups.

Authors:  C Vrieling; L Collette; A Fourquet; W J Hoogenraad; J H Horiot; J J Jager; M Pierart; P M Poortmans; H Struikmans; B Maat; E Van Limbergen; H Bartelink
Journal:  Radiother Oncol       Date:  2000-06       Impact factor: 6.280

7.  Objective assessment of cosmetic outcome after targeted intraoperative radiotherapy in breast cancer: results from a randomised controlled trial.

Authors:  Mohammed R S Keshtgar; Norman R Williams; Max Bulsara; Christobel Saunders; Henrik Flyger; Jaime S Cardoso; Tammy Corica; Neils Bentzon; Nikolaos V Michalopoulos; David J Joseph
Journal:  Breast Cancer Res Treat       Date:  2013-07-23       Impact factor: 4.872

8.  Quality of life over 5 years in women with breast cancer after breast-conserving therapy versus mastectomy: a population-based study.

Authors:  Volker Arndt; Christa Stegmaier; Hartwig Ziegler; Hermann Brenner
Journal:  J Cancer Res Clin Oncol       Date:  2008-05-27       Impact factor: 4.553

9.  Breast retraction assessment. Multiple variable analysis of factors responsible for cosmetic retraction in patients treated conservatively for stage I or II breast carcinoma.

Authors:  R D Pezner; M P Patterson; L R Hill; N L Vora; K R Desai; J A Lipsett
Journal:  Acta Radiol Oncol       Date:  1985 Jul-Aug

10.  The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials.

Authors:  Joanne S Haviland; J Roger Owen; John A Dewar; Rajiv K Agrawal; Jane Barrett; Peter J Barrett-Lee; H Jane Dobbs; Penelope Hopwood; Pat A Lawton; Brian J Magee; Judith Mills; Sandra Simmons; Mark A Sydenham; Karen Venables; Judith M Bliss; John R Yarnold
Journal:  Lancet Oncol       Date:  2013-09-19       Impact factor: 41.316

View more
  3 in total

1.  Cosmetic changes following surgery and accelerated partial breast irradiation using HDR interstitial brachytherapy : Evaluation by a multidisciplinary/multigender committee.

Authors:  Tamer Soror; György Kovács; Nina Seibold; Corinna Melchert; Kristin Baumann; Eike Wenzel; Suzana Stojanovic-Rundic
Journal:  Strahlenther Onkol       Date:  2017-01-02       Impact factor: 3.621

Review 2.  Intraoperative Radiotherapy for Breast Cancer.

Authors:  Eleanor E R Harris; William Small
Journal:  Front Oncol       Date:  2017-12-22       Impact factor: 6.244

3.  Assessment of non-inferiority with meta-analysis: example of hypofractionated radiation therapy in breast and prostate cancer.

Authors:  Jane-Chloé Trone; Edouard Ollier; Céline Chapelle; Patrick Mismetti; Michel Cucherat; Nicolas Magné; Paul Jacques Zuffrey; Silvy Laporte
Journal:  Sci Rep       Date:  2020-09-22       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.